Conference catch-up: Innovation, AI & the future of pharma deal-making

In this episode, we recap the key takeaways from BIO-Europe 2025, held in Milan, Italy, in March 2025, with Trajko Spasenovski, Vice President of Strategic Account Management at Evaluate, and Carolyn Hall, Senior Director of Content and Thought Leadership Marketing at Evaluate.

After the conference, Citeline’s Managing Editor, Meredith Landry, spoke with them about their experience there and what they learned about trends in early-stage deal-making, emerging areas like cardiovascular and rare disease therapies, and the expanding role of AI in R&D.

Trajko and Carolyn also share how conferences like BIO-Europe help Norstella and its clients forge meaningful partnerships, uncover market needs, and accelerate the path to life-saving therapies through data-driven insights and strategic collaboration.

meredith-landry-headshot
Meredith Landry
Managing Editor | Citeline
trajko-spasenovski-headshot
Trajko Spasenovski
VP, Strategic Account Management | Evaluate
carolyn-hall-headshot
Carolyn Hall
Senior Director, Content and Thought Leadership Marketing | Evaluate
norstella-podcast

Our AI capabilities are built to evolve—transforming data into insight, insight into action, and action into impact.